This site uses cookies to improve your experience. By viewing our content, you are accepting the use of cookies. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country we will assume you are from the United States. View our privacy policy and terms of use.

Remove Pharmacology Remove Physicians Remove Side effects Related Topics
Healthcare Provider Prescription FDA Food and Drug Administration Healthcare Networking Patients Sales Leads Recruitment More Related Topics >
article thumbnail

The potential of virtual reality-based therapy for serious mental disorders

Pharmaceutical Technology

AUGUST 12, 2022

Anti-psychotics come with the risk of side effects such as drowsiness, agitation and blurred vision, so virtual reality (VR) technologies that can enhance recovery without anti-psychotics are an attractive option. VR treatments can also retain the engaging elements of therapy due to the immersive experience they provide.

Food and Drug Administration 141
Food and Drug Administration Pharmacology Side effects Physicians 141
article thumbnail

Cala® Launches The Cala kIQ™ System, Offering Meaningful Tremor Relief for Patients With Essential Tremor and Now Parkinson’s Disease

Legacy MEDSearch

JUNE 15, 2023

The Cala kIQ System empowers patients and physicians by providing an on-demand, comfortable, at-home therapy for ease of use and management of action hand tremors. The Cala kIQ System with TAPS therapy offers a non-invasive, non-pharmacologic solution with minimal side effects.

Patients 98
Patients Recruitment Pharmacology Side effects 98
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

 

Stay Connected

Join 8,000+ Insiders by signing up for our newsletter

About
About
Editions
Editions
Topics
Powered by Aggregage | Terms and Conditions | Your California Rights and Privacy Policy
© Aggregage 2024